Cofepris’ CMN recommends the Cuban Abdala vaccine in children

2023-05-15 01:00:18

• Since the end of 2022, the Cuban Abdala vaccine has been applied in Mexico as a booster, but only to people of legal age.
• Now your coverage could be increased because it is also recommended for children 5 to 17 years of age.
• According to the Cofepris CMN, it has an efficacy against mild, moderate, and severe clinical forms of COVID-19 of 92.13 percent, 88.99 percent, and 92.33 percent, respectively.

To provide protection to the population against Covid-19, there are immunizations. The function of each one is not to avoid infections, but rather severe conditions that can lead to fatal cases. Among the options available in Mexico, there is one that has caused strong controversy and is the Cuban vaccine Abdala.

The biological made history because it was the first to be completely created and developed in Latin America. At the same time, among its detractors there are those who indicate that it lacks validity on the part of an international authority such as the World Health Organization (WHO).

Despite the above, from the end of 2022 the Cuban vaccine Abdala obtained the emergency use permit for its application among the Mexican population. During this first stage, it was used as a booster in adults, although its coverage could now be expanded.

According to the new indication, the vaccine developed by the Center for Genetic Engineering and Biotechnology (CIGB) of the Republic of Cuba is indicated for specific active immunization against SARS-CoV-2 infection in boys and girls from 5 years of age.

Vaccine efficacy in children

Based on what was published by the New Molecules Committee (CMN) of the Federal Commission for the Protection against Sanitary Risks (Cofepris), it has an efficacy against mild, moderate and severe clinical forms of COVID-19 of 92.13 percent, 88.99 percent. percent and 92.33 percent, respectively.

For the above the CMN issued a favorable opinion on the Cuban vaccine of recombinant protein of the receptor binding domain of the SARS-CoV-2 virus, known as Abdalaso that it can now be applied to children from 5 to 17 years of age.

It should be noted that the opinion issued by the CMN is part of the process to obtain emergency use authorization issued by the Cofepris Sanitary Authorization Commission, once the information presented has been evaluated.

Likewise, it is reported that on April 3, the Abdala vaccine obtained a favorable recommendation from the National Committee for Science, Technology and Innovation in Public Health (CNCTI-SP), of the now National Council of Humanities, Sciences and Technologies (Conahcyt). for the extension of the indication of emergency use of the Abdala vaccine against COVID-19 for primary vaccination in the pediatric population from 5 to 17 years of age.

Since 2021, the Center for the State Control of Medicines, Equipment and Medical Devices (Cecmed) of Cuba authorized the emergency use of said vaccine in that country, confirming that it met the requirements and parameters in terms of quality, safety and efficacy. .

All vaccines that are applied in Mexico are free

For its part, Cofepris emphasized that the supply of vaccines to prevent the pandemic is universal and free. In Mexico, its application is established in the National Vaccination Policy against the SARS-CoV-2 virus, for the Prevention of COVID-19.

Therefore, the application of any supposed vaccine against the SARS-CoV-2 virus in spaces, laboratories, hospitals and clinics not designated by the authority represents a health risk. If an establishment is detected that offers any product posing as a vaccine against COVID-19, a health complaint in the following link.

Also read:

Efficacy and side effects of the Abdala vaccine against Covid-19

Doctors discuss on social networks the Cuban vaccine Abdala: They are for and against

At last! The first shipment of the Cuban Abdala vaccine arrives in Mexico